NCT06571110 Analgesic Response to Opioids in Patients With Fibromyalgia After Conventional Acupuncture Versus Sham Acupuncture
| NCT ID | NCT06571110 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Irvine |
| Condition | Fibromyalgia |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2025-03-15 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2025-03-15 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to see whether acupuncture can help fibromyalgia patients by giving them acupuncture treatment and seeing whether acupuncture helps enhance the effects of an opioid.
Eligibility Criteria
Inclusion Criteria: * Are 18 - 80 years old * have been diagnosed with Fibromyalgia for more than 6 months * Are already using chronic, continuous opioid therapy, including but not limited to the use of Hydrocodone (Norco), Oxycodone (Percocet), morphine, methadone or Tylenol #3 daily * Have moderate to excruciating pain at baseline, determined by a 5 or greater score on the Visual Analogue Scale (VAS) Exclusion Criteria: * Are younger than 18 or older than 80 years old * Have been diagnosed with a Substance Use Disorder (SUD) * Pregnant * Have an active litigation or worker's compensation case * Have an active mental health diagnosis, such as bipolar disorder, psychosis, or suicidal ideation * Are prescribed and actively using low dose Naltrexone . Have tried acupuncture in the last 6 months
Contact & Investigator
Ariana Nelson, MD
PRINCIPAL INVESTIGATOR
University of California, Irvine
Frequently Asked Questions
Who can join the NCT06571110 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06571110 currently recruiting?
Yes, NCT06571110 is actively recruiting participants. Contact the research team at skhanahm@hs.uci.edu for enrollment information.
Where is the NCT06571110 trial being conducted?
This trial is being conducted at Irvine, United States.
Who is sponsoring the NCT06571110 clinical trial?
NCT06571110 is sponsored by University of California, Irvine. The principal investigator is Ariana Nelson, MD at University of California, Irvine. The trial plans to enroll 45 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.